NLRP3, NLRC4, and AIM2 play critical roles in the progression of MS, probably by mediating Th1 and Th17 responses. It seems that decreased expression of IL‐1β is related to decreased production and also functions of inflammasomes. This evidence concerns the gene NLRP3 and myeloid sarcoma.